日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli O7:K1 UPF0115 protein yfcN (yfcN) CSB-YP487219EON
CSB-EP487219EON
CSB-BP487219EON
CSB-MP487219EON
CSB-EP487219EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Glycine--tRNA ligase alpha subunit (glyQ) CSB-YP487220EON
CSB-EP487220EON
CSB-BP487220EON
CSB-MP487220EON
CSB-EP487220EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 ADP-L-glycero-D-manno-heptose-6-epimerase (hldD) CSB-YP487221EON
CSB-EP487221EON
CSB-BP487221EON
CSB-MP487221EON
CSB-EP487221EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 UPF0145 protein ybjQ (ybjQ) CSB-YP487222EON
CSB-EP487222EON
CSB-BP487222EON
CSB-MP487222EON
CSB-EP487222EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 D-tagatose-1,6-bisphosphate aldolase subunit gatZ (gatZ) CSB-YP487223EON
CSB-EP487223EON
CSB-BP487223EON
CSB-MP487223EON
CSB-EP487223EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 DNA ligase (ligA) CSB-YP487224EON
CSB-EP487224EON
CSB-BP487224EON
CSB-MP487224EON
CSB-EP487224EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Ethanolamine ammonia-lyase light chain (eutC) CSB-YP487225EON
CSB-EP487225EON
CSB-BP487225EON
CSB-MP487225EON
CSB-EP487225EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Putative multidrug resistance protein MdtD (mdtD), partial CSB-YP487226EON
CSB-EP487226EON
CSB-BP487226EON
CSB-MP487226EON
CSB-EP487226EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Histidinol-phosphate aminotransferase (hisC) CSB-YP487227EON
CSB-EP487227EON
CSB-BP487227EON
CSB-MP487227EON
CSB-EP487227EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 DnaA-homolog protein hda (hda) CSB-YP487228EON
CSB-EP487228EON
CSB-BP487228EON
CSB-MP487228EON
CSB-EP487228EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Adenine deaminase (ade) CSB-YP487229EON
CSB-EP487229EON
CSB-BP487229EON
CSB-MP487229EON
CSB-EP487229EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 D-galactonate dehydratase (dgoD) CSB-YP487230EON
CSB-EP487230EON
CSB-BP487230EON
CSB-MP487230EON
CSB-EP487230EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Bifunctional protein GlmU (glmU) CSB-YP487231EON
CSB-EP487231EON
CSB-BP487231EON
CSB-MP487231EON
CSB-EP487231EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Aspartate--ammonia ligase (asnA) CSB-YP487232EON
CSB-EP487232EON
CSB-BP487232EON
CSB-MP487232EON
CSB-EP487232EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Molecular chaperone Hsp31 and glyoxalase 3 (hchA) CSB-YP487233EON
CSB-EP487233EON
CSB-BP487233EON
CSB-MP487233EON
CSB-EP487233EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP487234EON
CSB-EP487234EON
CSB-BP487234EON
CSB-MP487234EON
CSB-EP487234EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Co-chaperone protein hscB (hscB) CSB-YP487235EON
CSB-EP487235EON
CSB-BP487235EON
CSB-MP487235EON
CSB-EP487235EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 3-phenylpropionate/cinnamic acid dioxygenase subunit beta (hcaF) CSB-YP487236EON
CSB-EP487236EON
CSB-BP487236EON
CSB-MP487236EON
CSB-EP487236EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP487237EON
CSB-EP487237EON
CSB-BP487237EON
CSB-MP487237EON
CSB-EP487237EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 tRNA1 (Val) (adenine (37)-N6)-methyltransferase CSB-YP487238EON
CSB-EP487238EON
CSB-BP487238EON
CSB-MP487238EON
CSB-EP487238EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×